Abstract:Δ1‐pyrroline‐5‐carboxylate reductase isoform 1 (PYCR1) is the last enzyme of proline biosynthesis and catalyzes the NAD(P)H‐dependent reduction of Δ1‐pyrroline‐5‐carboxylate to L‐proline. High PYCR1 gene expression is observed in many cancers and linked to poor patient outcomes and tumor aggressiveness. The knockdown of the PYCR1 gene or the inhibition of PYCR1 enzyme has been shown to inhibit tumorigenesis in cancer cells and animal models of cancer, motivating inhibitor discovery. We screened a library of 71 low molecular weight compounds (average MW of 131 Da) against PYCR1 using an enzyme activity assay. Hit compounds were validated with X‐ray crystallography and kinetic assays to determine affinity parameters. The library was counter‐screened against human Δ1‐pyrroline‐5‐carboxylate reductase isoform 3 and proline dehydrogenase (PRODH) to assess specificity/promiscuity. Twelve PYCR1 and one PRODH inhibitor crystal structures were determined. Three compounds inhibit PYCR1 with competitive inhibition parameter of 100 μM or lower. Among these, (S)‐tetrahydro‐2H‐pyran‐2‐carboxylic acid (70 μM) has higher affinity than the current best tool compound N‐formyl‐l‐proline, is 30 times more specific for PYCR1 over human Δ1‐pyrroline‐5‐carboxylate reductase isoform 3, and negligibly inhibits PRODH. Structure‐affinity relationships suggest that hydrogen bonding of the heteroatom of this compound is important for binding to PYCR1. The structures of PYCR1 and PRODH complexed with 1‐hydroxyethane‐1‐sulfonate demonstrate that the sulfonate group is a suitable replacement for the carboxylate anchor. This result suggests that the exploration of carboxylic acid isosteres may be a promising strategy for discovering new classes of PYCR1 and PRODH inhibitors. The structure of PYCR1 complexed with l‐pipecolate and NADH supports the hypothesis that PYCR1 has an alternative function in lysine metabolism.

Crystal Structure of Human Pyrroline-5-Carboxylate Reductase

Purification, Characterization and Crystallization of Pyrroline-5-Carboxylate Reductase from the Hyperthermophilic Archeon Sulfolobus Solfataricus

Purification and Characterization of Pyrroline-5-carboxylate Reductase from Drosophila Melanogaster

Crystal Structure of Perakine Reductase, Founding Member of A Novel Aldo-Keto Reductase (akr) Subfamily That Undergoes Unique Conformational Changes During Nadph Binding

Purification and characterization of a functionally active Mycobacterium tuberculosis pyrroline-5-carboxylate reductase.

Functional Characterization of Saccharomyces cerevisiae P5C Reductase, the Enzyme at the Converging Point of Proline and Arginine Metabolism

Purification, Crystallization and Preliminary X-Ray Studies of Gmp Reductase 2 from Human

Purification, Crystallization and Preliminary Crystallographic Analysis of Cytochrome P450 203A1 from Rhodopseudomonas Palustris.

Crystal Structure Of A Carbonyl Reductase From Candida Parapsilosis With Anti-Prelog Stereospecificity

Crystal structure of human guanosine monophosphate reductase 2 (GMPR2) in complex with GMP.

Crystallization and preliminary X-ray diffraction studies of a ferredoxin reductase from Rhodopseudomonas palustris CGA009.

The crystal structure of the S154Y mutant carbonyl reductase from Leifsonia xyli explains enhanced activity for 3,5-bis(trifluoromethyl)acetophenone reduction

Expression, Purification, Crystallization and Preliminary X-ray Analysis of Perakine Reductase, a New Member of the Aldo-Keto Reductase Enzyme Superfamily from Higher Plants

Crystal structure of human pyridoxal kinase.

Effect of the R119G Mutation on Human P5CR Structure and Its Interactions with NAD: Insights Derived from Molecular Dynamics Simulation and Free Energy Analysis.

Crystal structure of glutathione reductase Glr1 from the yeastSaccharomyces cerevisiae

Ph-Profile Crystal Structure Studies of C-terminal Despentapeptide Nitrite Reductase from Achromobacter Cycloclastes

Screening a knowledge‐based library of low molecular weight compounds against the proline biosynthetic enzyme 1‐pyrroline‐5‐carboxylate 1 (PYCR1)

Crystal Structure of the Catalytic Domain of a New Human Thioredoxin-Like Protein

Crystal structure determination and mutagenesis analysis of the ene reductase NCR

Structural Insights on the Catalytic Site Protection of Human Carbonyl Reductase 1 by Glutathione